mianserin has been researched along with Bone Cancer in 1 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, CC | 1 |
| Cheng, HH | 1 |
| Huang, CJ | 1 |
| Lu, YC | 1 |
| Chen, IS | 1 |
| Liu, SI | 1 |
| Hsu, SS | 1 |
| Chang, HT | 1 |
| Huang, JK | 1 |
| Chen, JS | 1 |
| Jan, CR | 1 |
1 other study available for mianserin and Bone Cancer
| Article | Year |
|---|---|
The antidepressant mirtazapine-induced cytosolic Ca2+ elevation and cytotoxicity in human osteosarcoma cells.
Topics: Antidepressive Agents, Tricyclic; Bone Neoplasms; Calcium; Calcium Signaling; Cell Line, Tumor; Cell | 2006 |